- Home
- NML vs DNA Comparison
NML vs DNA Comparison
Compare NML & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NML
- DNA
- Stock Information
- Founded
- NML 2012
- DNA 2008
- Country
- NML United States
- DNA United States
- Employees
- NML N/A
- DNA N/A
- Industry
- NML Finance/Investors Services
- DNA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NML Finance
- DNA Health Care
- Exchange
- NML Nasdaq
- DNA Nasdaq
- Market Cap
- NML 454.4M
- DNA 466.4M
- IPO Year
- NML N/A
- DNA N/A
- Fundamental
- Price
- NML $8.77
- DNA $7.49
- Analyst Decision
- NML
- DNA Sell
- Analyst Count
- NML 0
- DNA 3
- Target Price
- NML N/A
- DNA $9.67
- AVG Volume (30 Days)
- NML 219.3K
- DNA 1.1M
- Earning Date
- NML 01-01-0001
- DNA 05-06-2025
- Dividend Yield
- NML 9.75%
- DNA N/A
- EPS Growth
- NML N/A
- DNA N/A
- EPS
- NML N/A
- DNA N/A
- Revenue
- NML N/A
- DNA $237,417,000.00
- Revenue This Year
- NML N/A
- DNA N/A
- Revenue Next Year
- NML N/A
- DNA $15.26
- P/E Ratio
- NML N/A
- DNA N/A
- Revenue Growth
- NML N/A
- DNA 13.76
- 52 Week Low
- NML $6.09
- DNA $5.00
- 52 Week High
- NML $7.33
- DNA $23.24
- Technical
- Relative Strength Index (RSI)
- NML 58.77
- DNA 50.94
- Support Level
- NML $8.31
- DNA $6.65
- Resistance Level
- NML $8.63
- DNA $7.62
- Average True Range (ATR)
- NML 0.15
- DNA 0.49
- MACD
- NML 0.01
- DNA -0.03
- Stochastic Oscillator
- NML 79.31
- DNA 49.26
About NML Neuberger Berman Energy Infrastructure and Income Fund Inc.
Neuberger Berman Energy Infrastructure & Income Fund Inc is a closed-end investment management company based in the United States. Invest in Capital Markets, Chemicals, Oil, Gas & Consumable Fuels, Electric Utilities, Independent Power and Renewable Electricity Producers, Multi Utilities. Maximum is done in Oil, Gas & Consumable Fuels.
About DNA Ginkgo Bioworks Holdings Inc.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.